Nataj Majd Masoomeh, Moini Ashraf, Samimi Sadeh Saghar, Bastanhagh Ehsan
Department of Anesthesiology, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Obstetrics and Gynecology, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Int J Reprod Biomed. 2023 Jan 9;20(12):1013-1018. doi: 10.18502/ijrm.v20i12.12562. eCollection 2022 Dec.
Endometrial receptivity is crucial for embryo implantation, and excessive uterine contraction reduces success. Nifedipine which is a calcium channel blocker, could decrease uterine contraction and improve pregnancy outcomes.
This study aimed to assess the effect of Nifedipine before embryo transfer on the pregnancy outcome in women undergoing in vitro fertilization (IVF) in a tertiary center in Iran.
150 women who were candidates for IVF were randomly assigned into 2 groups: group 1 received 20 mg Nifedipine 30 min before embryo transfer, and group 2 received no intervention. Blood pressure of the participants was monitored every 10 min for 1 hr under the supervision of an anesthesiologist. Finally, implantation rate and chemical and clinical pregnancy rates were compared between groups.
At the end of the study, 140 participants were included in the final analyses. No significant difference was observed in clinical pregnancy rates between groups (20% vs. 22%, p = 0.51).
Nifedipine administration before embryo transfer does not improve the implantation and clinical pregnancy rates in women undergoing IVF.
子宫内膜容受性对胚胎着床至关重要,而子宫过度收缩会降低成功率。硝苯地平作为一种钙通道阻滞剂,可减少子宫收缩并改善妊娠结局。
本研究旨在评估在伊朗一家三级中心接受体外受精(IVF)的女性中,胚胎移植前使用硝苯地平对妊娠结局的影响。
150名拟接受IVF的女性被随机分为两组:第1组在胚胎移植前30分钟服用20毫克硝苯地平,第2组不进行干预。在麻醉医生的监督下,每10分钟监测参与者的血压,持续1小时。最后,比较两组之间的着床率、化学妊娠率和临床妊娠率。
研究结束时,140名参与者纳入最终分析。两组之间的临床妊娠率无显著差异(20%对22%,p = 0.51)。
胚胎移植前使用硝苯地平并不能提高接受IVF女性的着床率和临床妊娠率。